Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure: Results from the REcently Decompensated Heart failure Anakinra Response Trial (REDHART)

BACKGROUND: An enhanced inflammatory response predicts worse outcomes in heart failure (HF). We hypothesized that administration of Interleukin-1 (IL-1) receptor antagonist (anakinra) could inhibit the inflammatory response and improve peak aerobic exercise capacity in patients with recently decompe...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Circ Heart Fail
Prif Awduron: Van Tassell, Benjamin W., Canada, Justin, Carbone, Salvatore, Trankle, Cory, Buckley, Leo, Erdle, Claudia Oddi, Abouzaki, Nayef A., Dixon, Dave, Kadariya, Dinesh, Christopher, Sanah, Schatz, Aaron, Regan, Jessica, Viscusi, Michele, Buono, Marco Del, Melchior, Ryan, Mankad, Pranav, Lu, Juan, Sculthorpe, Robin, Biondi-Zoccai, Giuseppe, Lesnefsky, Edward, Arena, Ross, Abbate, Antonio
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2017
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5699505/
https://ncbi.nlm.nih.gov/pubmed/29141858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCHEARTFAILURE.117.004373
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg